Chris Hoyt

Chris Hoyt is currently the Chief Executive Officer at KeifeRx, where Chris focuses on developing disease-modifying therapies for neurodegenerative diseases. Chris is also a Venture Partner at Moonshots Capital, Chairman at Yet Analytics, Inc., an investor at 868 Estate Vineyards, and a board member at Goodworld. Previously, Chris was the Co-Founder & CFO at Upskill, a technology company that was later acquired by TeamViewer AG, and also served as a Co-Founder and Board Member at the Digital Harbor Foundation. Hoyt has a BSBA in International Finance from American University and has a wealth of experience in the healthcare, technology, and non-profit sectors.